Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma

NAEnrolling by invitationINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

cytosponge

Use of cytosponge as a tool to patients who need surveillance after endoscopic submucosal dissection for esophageal squamous cell carcinoma

Trial Locations (1)

200433

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

Tongliao City Hospital

UNKNOWN

collaborator

Ankang Central Hospital

OTHER

collaborator

Yancheng First People's Hospital

OTHER

collaborator

Lianshui County People's Hospital

UNKNOWN

collaborator

Nanchong Central Hospital

OTHER_GOV

collaborator

Henan Provincial People's Hospital

OTHER

collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

collaborator

Zhongda Hospital

OTHER

collaborator

Affiliated hospital of nanjing university hospital of Chinese medicine

UNKNOWN

lead

Changhai Hospital

OTHER